A. Chawla

发表

Impact of the COVID-19 Pandemic on Cancer Clinical Trials

S. Mandrekar, S. Hillman, J. Boughey, 2021, Annals of Surgical Oncology.

ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer—Standard of Care or Still Worth Debating?

Jiping Wang, A. Chawla, 2019, Annals of Surgical Oncology.

Current and developing immunotherapy in gastric adenocarcinoma

Jia Wei, Jiping Wang, A. Chawla, 2017 .

Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer.

A. Ibrahim, J. Ammori, Tiffany L Huang, 2018, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Immune checkpoints

E. Mittendorf, A. Philips, G. Alatrash, 2014, Oncoimmunology.

Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells

E. Mittendorf, A. Philips, I. Diaconu, 2016, Cancer Immunology, Immunotherapy.

Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma

Jeffrey W. Clark, K. Lillemoe, O. Catalano, 2020, Annals of surgery.

Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer

G. Molina, J. Mancias, B. Wolpin, 2019, Annals of Surgical Oncology.

Utility of circulating tumor DNA for predicting prognosis in the management of resectable pancreatic cancer

Felix Nwajei, Zachary Tyerman, C. Schlick, 2022, Journal of Cancer Metastasis and Treatment.

Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines.

M. Suguitan, A. Chawla, Cade Bennett, 2022, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Squamous cell carcinoma of the anal canal and anal margin.

C. Willett, A. Chawla, Christopher G. Willett, 2001, Hematology/oncology clinics of North America.

PD-L1 Expression in Triple-Negative Breast Cancer

P. Sharma, F. Meric-Bernstam, Yun Wu, 2014, Cancer Immunology Research.

Pancreatic Cancer: A Review.

E. O’Reilly, W. Park, A. Chawla, 2021, JAMA.

Neoadjuvant Therapy for Resectable Pancreatic Cancer: An Evolving Paradigm Shift

C. Ferrone, A. Chawla, 2019, Front. Oncol..

Perioperative Management of Patients Undergoing CRS and HIPEC

J. Cusack, Z. Fong, Grant Backer, 2020 .

Staging Classification and Stratification of Pancreatic Cancer for Clinical Practice

A. Aguirre, A. Chawla, 2021 .

Inoperable Biliary Tract and Primary Liver Tumors: Palliative Treatment Options.

Sophia K. McKinley, C. Ferrone, A. Chawla, 2019, Surgical oncology clinics of North America.

Immune aspects of the breast tumor microenvironment.

Yun Wu, E. Mittendorf, G. Alatrash, 2013, Breast cancer management.

PD-L 1 Expression in Triple-Negative Breast Cancer

P. Sharma, F. Meric-Bernstam, Yun Wu, 2014 .

Pathological treatment response has different prognostic implications for pancreatic cancer patients treated with neoadjuvant chemotherapy or chemoradiotherapy.

K. Lillemoe, W. Burns, elliot k fishman, 2021, Surgery.

Contemporary trials evaluating neoadjuvant therapy for resectable pancreatic cancer

A. Chawla, 2021, Journal of surgical oncology.

Clinical staging in pancreatic adenocarcinoma underestimates extent of disease.

K. Lillemoe, D. Ryan, T. Hong, 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI

N. Bardeesy, V. Deshpande, M. Qadan, 2020, Clinical Cancer Research.

Neoadjuvant chemotherapy is associated with altered immune cell infiltration and an anti-tumorigenic microenvironment in resected pancreatic cancer.

Hannah L Williams, A. Koong, A. Hezel, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Surgical considerations in patients receiving neoadjuvant systemic therapy.

K. Hunt, E. Mittendorf, A. Chawla, 2012, Future oncology.

Surgeon-Led Clinical Trials in Pancreatic Cancer.

C. Ferrone, A. Chawla, 2022, Surgical oncology clinics of North America.

Hepatocellular carcinoma surgical therapy: perspectives on the current limits to resection.

C. Ferrone, A. Chawla, 2018, Chinese Clinical Oncology.

The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors

D. Bentrem, J. Abad, A. Chawla, 2023, Journal of surgical oncology.

Impact of the COVID-19 Pandemic on Cancer Clinical Trials

S. Mandrekar, S. Hillman, J. Boughey, 2021 .

Pancreaticoduodenectomy and metastasectomy for metastatic pancreatic neuroendocrine tumors

S. Ashley, T. Clancy, C. Pezzi, 2018, Journal of surgical oncology.

The role of oncologic resection and enucleation for small pancreatic neuroendocrine tumors.

J. Abad, A. Chawla, M. Altimari, 2021, HPB : the official journal of the International Hepato Pancreato Biliary Association.

The differential effect of neoadjuvant chemotherapy and chemoradiation on nodal downstaging in pancreatic adenocarcinoma.

J. Abad, A. Chawla, Amy Wells, 2023, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Surgical Palliation for Advanced Pancreas Cancer.

A. Chawla, Dominic J Vitello, Caitlin S. Jacobs, 2024, The Surgical clinics of North America.

Utilization and survival outcomes of neoadjuvant chemotherapy for early-stage gastric cancer.

D. Bentrem, A. Chawla, Lauren M. Janczewski, 2024, Journal of surgical oncology.

Utilization of Neoadjuvant Therapy for Localized Gastric Gastrointestinal Stromal Tumors and the Association with Survival.

A. Chawla, Lauren M. Janczewski, Dominic J Vitello, 2024, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.